← Back to Clinical Trials
Recruiting NCT04610697

NCT04610697 Cognitive Remediation in Forensic Mental Health Care

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04610697
Status Recruiting
Phase
Sponsor The Royal Ottawa Mental Health Centre
Condition Psychotic Disorders
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2020-02-10
Primary Completion 2026-02-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Cognitive RemediationActive Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2020-02-10 with a primary completion date of 2026-02-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Forensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. One empirically-validated method to train executive functions is cognitive remediation, which consists of cognitive exercises combined with coaching. This trial investigates whether cognitive remediation can improve cognitive, functional, and clinical outcomes in forensic inpatients.

Eligibility Criteria

Inclusion Criteria: i1. Age 18 - 55; i2. Ability to read and speak in fluent English; i3. Current status as inpatient on the Forensic Treatment Unit. Exclusion Criteria: e1. Intellectual disability; e2. TBI with loss of consciousness followed by known severe neurological sequelae requiring hospitalisation and rehabilitation.

Contact & Investigator

Central Contact

Patrizia Pezzoli, PhD

✉ p.pezzoli@ucl.ac.uk

📞 613-722-6521

Principal Investigator

Patrizia Pezzoli, PhD

PRINCIPAL INVESTIGATOR

UCL and The Royal's Institute of Mental Health Research

Frequently Asked Questions

Who can join the NCT04610697 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Psychotic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04610697 currently recruiting?

Yes, NCT04610697 is actively recruiting participants. Contact the research team at p.pezzoli@ucl.ac.uk for enrollment information.

Where is the NCT04610697 trial being conducted?

This trial is being conducted at Ottawa, Canada.

Who is sponsoring the NCT04610697 clinical trial?

NCT04610697 is sponsored by The Royal Ottawa Mental Health Centre. The principal investigator is Patrizia Pezzoli, PhD at UCL and The Royal's Institute of Mental Health Research. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology